Search
healthcare › clinical-trials › h-56035
… S2303 PARAMMUNE: Randomized Phase II/III Trial of 2nd Line Nivolumab + … + Ramucirumab in Patients With PD-L1 CPS Advanced Gastric and Esophageal Adenocarcinoma … This phase II/III trial compares the addition of nivolumab to … PARAMUNE Trial: Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer …
departments › ... › admissions
… a picture of the department as is possible in a short visit. … CST Register for Menninger/BCM Psychiatry Open House 2025-2026 … accepting PGY-II transfer applications for academic year 26-27. Please check back in fall 2026 regarding the availability of transfer positions for …
healthcare › ... › meet-our-team
… College of Medicine’s board-certified gynecologists are highly respected for the quality of clinical and surgical care they provide, and the impact they are making on women’s health at …
research › ... › news
… Hamed presented our work at the 26th International Symposium on Glycoconjugates (Glyco26) in Taiwan. … from Professor Hideyuki Takeuchi's group in Japan will be a visiting postdoctoral associate in our group. …
healthcare › ... › lions-eye-bank
… For more information on Lions Clubs International , please visit their website. …
healthcare › ... › breast-cancer-treatment-options
… for a short time and then you have three to four weeks off before beginning another cycle. Chemo is most often used …
healthcare › clinical-trials › h-44098
… Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to … The purpose of this study is to test the effectiveness of the study drug oral ozanimod as a treatment for … this study if: You are a male or female between the ages of 18 and 75; You have an established diagnosis of Crohn’s …
healthcare › clinical-trials › h-42481
… The purpose of this study is to compare the usual approach (no more treatment, additional … Testing Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple-Negative Breast Cancer …
about-us › ... › organ-donation-policy
… someone is added to the national transplant waiting list. Unfortunately, nearly half of all listed candidates will die waiting for a transplant. Research suggests there are … (OPOs). Baylor College of Medicine supports these efforts – firmly believing that more accountability is needed …